Northwestern Mutual Wealth Management
EWTX icon

Northwestern Mutual Wealth Management’s Edgewise Therapeutics EWTX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-489
Closed -$12.1K – 4239
2025
Q4 		$12.1K Buy
+489
New +$9.82K ﹤0.01% 2923
2024
Q1 		– Sell
-100
Closed -$1.09K – 3637
2023
Q4 		$1.09K Buy
+100
New +$702 ﹤0.01% 3161

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Northwestern Mutual Wealth Management's EWTX Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of Edgewise Therapeutics (EWTX) in Q1 2026, closing a stake of 489 shares — an estimated $12.1K sold.

Northwestern Mutual Wealth Management first reported a position in EWTX in Q4 2023 and held it in 2 quarters. The position peaked at $12.1K in Q4 2025. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Northwestern Mutual Wealth Management reported no remaining Edgewise Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 489 Edgewise Therapeutics shares in Q1 2026, an estimated $12.1K.
  • Northwestern Mutual Wealth Management first reported a position in Edgewise Therapeutics in Q4 2023 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Edgewise Therapeutics position peaked at $12.1K in Q4 2025.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.